UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quality evaluation of human and environmental toxicity studies performed with nanomaterials - the GUIDEnano approach

Environmental science. Nano, 2018, Vol.5 (2), p.381-397

2018

Volltextzugriff (PDF)

Polypharmacy and Crohn's disease

Alimentary pharmacology & therapeutics, 2005-05, Vol.21 (10), p.1211-1216

2005

Volltextzugriff (PDF)

The Management of Anal Fissure: ACPGBI Position Statement

Colorectal disease, 2008-11, Vol.10 (s3), p.1-7

2008

Volltextzugriff (PDF)

Pericardial Manifestations in Inflammatory Bowel Disease: A Report of Two Cases

Crohn's & colitis 360, 2019-10, Vol.1 (3)

2019

Volltextzugriff (PDF)

Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2021-10, Vol.161 (4), p.1340-1343.e2

2021

Volltextzugriff (PDF)

Narcotic Use in Patients with Crohn's Disease

The American journal of gastroenterology, 2005-10, Vol.100 (10), p.2225-2229

2005

Volltextzugriff (PDF)

Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases

Clinical gastroenterology and hepatology, 2022-08, Vol.20 (8), p.1881-1883.e1

2022

Volltextzugriff (PDF)

Protective Role of Arginase in a Mouse Model of Colitis

The Journal of immunology (1950), 2004-08, Vol.173 (3), p.2109-2117

2004

Volltextzugriff (PDF)

DOP64 Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn’s Disease: Post hoc results from the phase 3b SEQUENCE trial

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i190-i190

2024

Volltextzugriff (PDF)

P142 Role of e-health in the management of Inflammatory Bowel Disease: A systematic review and meta-analysis

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S227-S228

2021

Volltextzugriff (PDF)

Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported Outcomes

Drug design, development and therapy, 2023-01, Vol.17, p.273-282

2023

Volltextzugriff (PDF)

DOP16 Safety of long-term ozanimod treatment for up to 4 years in patients with moderately to severely active Ulcerative Colitis: an interim analysis of the True North open-label extension

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i100-i101

2024

Volltextzugriff (PDF)

Primary anastomosis without colonic lavage for the obstructed left colon

Annals of the Royal College of Surgeons of England, 2008-05, Vol.90 (4), p.302-304

2008

Volltextzugriff (PDF)

DOP45 Long-term cardiac safety of ozanimod in phase 3 clinical program of Ulcerative Colitis and relapsing multiple sclerosis

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i094-i095

2022

Volltextzugriff (PDF)

P187 Change in Urgency Status Among Ulcerative Colitis Patients: Understanding the Impact of Treatment Changes from the Corrona Inflammatory Bowel Disease Registry

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S256-S257

2021

Volltextzugriff (PDF)

Exercise in patients with inflammatory bowel diseases: current perspectives

Clinical and Experimental Gastroenterology, 2018-01, Vol.11, p.1-11

2018

Volltextzugriff (PDF)

Adverse events in IBD: to stop or continue immune suppressant and biologic treatment

Expert review of gastroenterology & hepatology, 2014-03, Vol.8 (3), p.223-240

2014

Volltextzugriff (PDF)

Personalized Treatment for Crohn's Disease: Current Approaches and Future Directions

Clinical and experimental gastroenterology, 2023-01, Vol.16, p.249-276

2023

Volltextzugriff (PDF)

Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3

Journal of Virology, 1977-06, Vol.22 (3), p.726-733

1977

Volltextzugriff (PDF)

Core outcome set for clinical studies of postoperative ileus after intestinal surgery

British journal of surgery, 2022-05, Vol.109 (6), p.493-496

2022

Volltextzugriff (PDF)

Core outcome set for clinical studies of postoperative ileus after intestinal surgery

British journal of surgery, 2022-06, Vol.109 (6), p.493-496

Tripartite Gastrointestinal Recovery Post-operative IIeus Group

2022

Volltextzugriff (PDF)

Nitric oxide in inflammatory bowel disease

Inflammatory bowel diseases, 2003-05, Vol.9 (3), p.179-189

2003

Volltextzugriff (PDF)

Involvement of Microtubules and 10-nm Filaments in the Movement and Positioning of Nuclei in Syncytia

The Journal of cell biology, 1979-11, Vol.83 (2), p.320-337

1979

Volltextzugriff (PDF)

Vedolizumab for the treatment of ulcerative colitis and Crohn's disease

Immunotherapy, 2012-09, Vol.4 (9), p.883-898

2012

Volltextzugriff (PDF)

Identification of a unique guanine-7-methyltransferase in Semliki forest virus (SFV) infected cell extracts

Virology (New York, N.Y.), 1983-10, Vol.130 (2), p.452-463

Cross, Rise K.

1983

Volltextzugriff (PDF)

1 – 25 von 2.992

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.432)
Mit Volltextzugriff
(2.458)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.968)
Japanisch
(14)
Deutsch
(8)
Norwegisch
(3)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Quality evaluation of human and environmental toxicity studies performed with nanomaterials - the GUIDEnano approach

Polypharmacy and Crohn's disease

The Management of Anal Fissure: ACPGBI Position Statement

Pericardial Manifestations in Inflammatory Bowel Disease: A Report of Two Cases

Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease

Narcotic Use in Patients with Crohn's Disease

Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases

Protective Role of Arginase in a Mouse Model of Colitis

DOP64 Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn’s Disease: Post hoc results from the phase 3b SEQUENCE trial

P142 Role of e-health in the management of Inflammatory Bowel Disease: A systematic review and meta-analysis

Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn's Disease: Patient Selection and Reported Outcomes

DOP16 Safety of long-term ozanimod treatment for up to 4 years in patients with moderately to severely active Ulcerative Colitis: an interim analysis of the True North open-label extension

Primary anastomosis without colonic lavage for the obstructed left colon

DOP45 Long-term cardiac safety of ozanimod in phase 3 clinical program of Ulcerative Colitis and relapsing multiple sclerosis

P187 Change in Urgency Status Among Ulcerative Colitis Patients: Understanding the Impact of Treatment Changes from the Corrona Inflammatory Bowel Disease Registry

Exercise in patients with inflammatory bowel diseases: current perspectives

Adverse events in IBD: to stop or continue immune suppressant and biologic treatment

Personalized Treatment for Crohn's Disease: Current Approaches and Future Directions

Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3

Core outcome set for clinical studies of postoperative ileus after intestinal surgery

Core outcome set for clinical studies of postoperative ileus after intestinal surgery

Nitric oxide in inflammatory bowel disease

Involvement of Microtubules and 10-nm Filaments in the Movement and Positioning of Nuclei in Syncytia

Vedolizumab for the treatment of ulcerative colitis and Crohn's disease

Identification of a unique guanine-7-methyltransferase in Semliki forest virus (SFV) infected cell extracts

Suchergebnisse filtern